The Johns Hopkins University researcher’s work helped solidify the link between human papillomavirus and cervical cancer, leading to the approval of the HPV vaccine in 2006.

The increased risk is slight, but aligns with a longstanding hypothesis that having more cells in one’s body leads to more chances for those cells to become cancerous.

A painting of the woman who was the source of HeLa cells will be on view at the National Portrait Gallery beginning May 15.

The US Food and Drug Administration approves a cervical test for human papillomavirus to be used as a primary cancer screening tool.

In contrast to yesterday’s news about the success of an HPV vaccine program in Australia, an Indian trial of the vaccine is stoking unfounded fear among the public and exposing some questionable ethical standards.

An HPV vaccination program in Australia appears to have resulted in a drop in cervical lesions among young women.